文献速递睡眠呼吸障碍呼吸危重症与机械通气

自动调节与手动调节无创通气治疗肥胖低通气综合征的有效性:一项随机临床试验

Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial.
PubMed 文献 · Am J Respir Crit Care Med · 2026-01-01

这项多中心、盲法、平行组、非劣效性及成本效果试验将205例初治门诊肥胖低通气综合征患者随机分配至自动调节无创通气组或手动调节无创通气组,主要终点为12个月日间PaCO2变化,非劣效界值为-2 mmHg。自动调节组每人节省1528欧元。结论认为自动调节无创通气长期有效性非劣于手动调节,且更具成本效果。

要点

  • 自动调节组每人节省1528欧元,成本效果更优。
  • 两组症状、生活质量及医疗资源利用等次要结局无显著差异。

核心结论

  • 在门诊肥胖低通气综合征患者中,自动调节无创通气长期有效性非劣于手动调节无创通气,且更具成本效果。

研究设计与样本

  • 多中心、盲法、平行组、非劣效性及成本效果随机临床试验,纳入205例初治门诊肥胖低通气综合征患者,自动调节组107例,手动调节组89例。

主要发现

  • 自动调节组PaCO2平均改善-9.2 mmHg(95%CI -9.7至-8.7),手动调节组-8.7 mmHg(95%CI -9.1至-8.3)。
  • 其他次要结局包括症状、生活质量及医疗资源利用无显著差异。

关键数值与推荐

  • 主要终点为12个月日间PaCO2变化,非劣效界值设定为-2 mmHg。

临床怎么用

  • 自动调节无创通气可考虑作为肥胖低通气综合征的优选方案,因其复杂性更低、成本更低且疗效非劣。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Obesity hypoventilation syndrome (OHS) is treated with noninvasive ventilation (NIV) that is titrated during polysomnography. Auto-adjusted NIV could obviate the need for polysomnographic titration, thereby reducing costs and delays in care. However, non-inferiority long-term clinical trials comparing auto-adjusted NIV with manually-adjusted NIV are lacking. OBJECTIVES: To determine the comparative effectiveness of automatic vs manual NIV modality in OHS. METHODS: In this multicenter, blinded, parallel group, non-inferiority and cost-effectiveness trial, we randomly assigned treatment-naïve ambulatory patients with OHS to auto-adjusted NIV (volume-targeted pressure support with auto-expiratory positive airway pressure) or manually-adjusted NIV (bilevel Positive Airway Pressure Spontaneous Timed mode (PAP ST). MEASUREMENTS: The primary outcome was change in daytime PaCO2 at 12 months, with the non-inferiority premise set at -2 mm Hg. Secondary outcomes included symptoms, quality of life, and healthcare resource utilization. Intention-to-treat and per-protocol analyses were performed. MAIN RESULTS: 205 ambulatory patients with OHS were randomized, 107 to auto-adjusted NIV and 89 to manually-adjusted NIV. The mean [95% CI] improvement in PaCO2 was -9.2 [-9.7; -8.7] mm Hg in the auto-adjusted group and -8.7 [-9.1; -8.3] mm Hg in the manually-adjusted group, with mean adjusted difference of 0.15 mm Hg between groups ([low confidence limit -1.4]; non-inferiority P = .01). Cost-effectiveness was favorable to auto-adjusted group with a saving of 1528 € (95% CI, -2 370; -6 854) per patient. There were no significant differences in other secondary outcomes. CONCLUSIONS: In ambulatory patients with OHS, auto-adjusted NIV had a non-inferior long-term effectiveness compared to manually-adjusted NIV while being more cost-effective. Auto-adjusted NIV may be preferred in clinical practice given its lower complexity and cost. CLINICALTRIAL.GOV IDENTIFIER: NCT04327336.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Sánchez-Quiroga MÁ, Benítez I, Mokhlesi B, et al. Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial. Am J Respir Crit Care Med. 2026. PMID: 41738216. doi:10.1093/ajrccm/aamag018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。